April 23, 2024

German National Cohort (NAKO): Longitudinal human data and biosamples as a resource for the life science community

German National Cohort (NAKO): Longitudinal human data and biosamples as a resource for the life science community
Go back
Join us for an exciting talk introducing NAKO as Germany’s largest long-term population study and a unique national research infrastructure. Learn about the scope, quality, and distinctive strengths of the NAKO data, and what makes it such a valuable resource for scientific discovery. Leo will also explain how to gain access and highlight the latest technical developments to help you make the most of this powerful dataset.
register now

Our latest News

discover more
NXTGN Startup Factory successful in international ranking

NXTGN Startup Factory successful in international ranking

New innovation platform with significant involvement from Heidelberg University is one of Europe’s most important start-up centers In its first year of existence, the NXTGN Startup Factory has already become one of Europe’s most important start-up centers. As an innovation platform, the strategic alliance of Baden-Württemberg universities and private-sector partners, with significant participation from Heidelberg […]

read more
Shingles vaccination could slow cognitive decline

Shingles vaccination could slow cognitive decline

New study shows benefits in all stages of dementia New findings indicate that a shingles vaccination could not only reduce the risk of cognitive impairment and dementia, but also have a positive effect on the course of the disease in patients who are already ill. Scientists from Heidelberg University’s Medical Faculty, the University of Mainz, […]

read more
3D microtumors could revolutionize treatment decisions

3D microtumors could revolutionize treatment decisions

Chemotherapy is often a central component of treatment for advanced colorectal cancer. However, not every therapy is equally effective for every patient. Researchers from the German Cancer Research Center (DKFZ), the HI-STEM* stem cell institute, and the biotech company Xilis in Utrecht, Netherlands, have now developed a new method for selecting the most effective drug […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp